Vivek Narayan Selected Research

Leuprolide (Lupron)

10/2021

Comparing Cardiovascular Outcomes With Degarelix or Leuprolide as Prostate Cancer Therapy-Applying Real-world Data to Clinical Trial Emulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vivek Narayan Research Topics

Disease

26	Neoplasms (Cancer) 03/2024 - 02/2012
16	Prostatic Neoplasms (Prostate Cancer) 03/2024 - 01/2017
9	Renal Cell Carcinoma (Grawitz Tumor) 02/2024 - 01/2016
7	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2017
5	Urinary Bladder Neoplasms (Bladder Cancer) 10/2019 - 05/2015
5	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 11/2008
4	Hypertension (High Blood Pressure) 10/2023 - 01/2016
4	Infections 07/2022 - 08/2011
4	Inflammation (Inflammations) 01/2018 - 01/2010
3	Heart Failure 01/2021 - 01/2018
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2017 - 12/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 01/2016
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 02/2024 - 10/2022
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2022
2	Second Primary Neoplasms (Neoplasms, Second) 01/2022 - 01/2020
2	Cardiotoxicity 01/2022 - 07/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2020
2	Viremia 12/2020 - 01/2018
2	Carcinoma (Carcinomatosis) 10/2019 - 01/2019
2	HIV Infections (HIV Infection) 01/2018 - 11/2008
1	Primitive Neuroectodermal Tumors (PNET) 02/2024
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2024
1	Serous Cystadenoma 02/2024
1	Spontaneous Fractures (Pathological Fracture) 11/2023
1	Thyroid Neoplasms (Thyroid Cancer) 10/2023
1	Leiomyosarcoma 01/2023
1	Bites and Stings (Sting) 01/2023
1	Hemorrhage 01/2023
1	Rare Diseases (Rare Disease) 10/2022
1	COVID-19 07/2022
1	Sepsis (Septicemia) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Insulin Resistance 09/2021
1	Periodontitis 09/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Vaccinia 12/2020
1	Disease Progression 12/2020

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
7	AndrogensIBA 03/2024 - 05/2019
6	Trastuzumab (Herceptin)FDA Link 01/2022 - 07/2017
4	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2022
4	Immune Checkpoint InhibitorsIBA 01/2023 - 10/2019
4	Cisplatin (Platino)FDA LinkGeneric 10/2019 - 05/2015
4	SeleniumIBA 08/2015 - 11/2008
3	AnthracyclinesIBA 01/2022 - 01/2019
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 01/2017
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 07/2017
3	Sunitinib (Sutent)FDA Link 01/2021 - 07/2017
2	RNA (Ribonucleic Acid)IBA 02/2024 - 11/2022
2	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 12/2020
2	Tyrosine Kinase InhibitorsIBA 10/2023 - 01/2021
2	cabozantinibIBA 01/2021 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 10/2019
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 01/2018
2	Complement System Proteins (Complement)IBA 07/2011 - 08/2009
1	lonidamineIBA 03/2024
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2024
1	belzutifanIBA 02/2024
1	Hormones (Hormone)IBA 11/2023
1	omega-Chloroacetophenone (Mace)IBA 10/2023
1	AntibodiesIBA 01/2023
1	AntigensIBA 01/2023
1	LigandsIBA 01/2023
1	Interferon Type IIBA 01/2023
1	talazoparibIBA 01/2023
1	avelumabIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 11/2022
1	ChlorhexidineIBA 07/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2022
1	MouthwashesIBA 07/2022
1	Povidone-Iodine (Betadine)FDA LinkGeneric 07/2022
1	arylesteraseIBA 01/2022
1	abirateroneIBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2022
1	Leuprolide (Lupron)FDA LinkGeneric 10/2021
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 10/2021
1	Glucose (Dextrose)FDA LinkGeneric 09/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2021
1	Blood Glucose (Blood Sugar)IBA 09/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	human ERBB2 proteinIBA 01/2021
1	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2021
1	CrizotinibIBA 01/2021
1	Proto-Oncogene Proteins c-metIBA 01/2021
1	Proteasome InhibitorsIBA 01/2021
1	VaccinesIBA 12/2020
1	GP 140IBA 12/2020
1	E coli heat-labile enterotoxinIBA 12/2020
1	IpilimumabIBA 10/2020
1	NivolumabIBA 10/2020

Therapy/Procedure

25	Therapeutics 03/2024 - 11/2008
7	Drug Therapy (Chemotherapy) 03/2024 - 12/2016
5	Radiotherapy 03/2024 - 01/2016
5	Immunotherapy 01/2023 - 10/2019
4	Castration 01/2023 - 10/2020
4	Neoadjuvant Therapy 01/2017 - 05/2015
2	Cystectomy 01/2018 - 07/2016
2	Salvage Therapy 01/2017 - 12/2016
1	Oral Hygiene (Dental Hygiene) 01/2023